Rush Medical College

Elevation Oncology Appoints Experienced Clinical Development Leaders Julie Cherrington, Ph.D. and Alan Sandler, M.D. to Board of Directors

Retrieved on: 
Monday, March 4, 2024
Neoplasm, Biotechnology, Senior, Indiana University, Food, Health, Drug development, Spacecraft, ADC, Stanford University, Doctor of Philosophy, University, Genentech, Safety, Roche, Therapy, Immunology, Food and Drug Administration, Abstract, Patient, Internal medicine, Oncology, Rush Medical College, Vanderbilt University, Publication, Mirati Therapeutics, Cancer, Pharmaceutical industry

"We are thrilled to welcome Julie and Alan as Elevation Oncology's newest directors," said Steve Elms, Chairman of Elevation Oncology.

Key Points: 
  • "We are thrilled to welcome Julie and Alan as Elevation Oncology's newest directors," said Steve Elms, Chairman of Elevation Oncology.
  • On behalf of the Board, I look forward to Julie and Alan's many insights into both clinical and regulatory strategy as Elevation Oncology continues to advance its pipeline of differentiated, potentially best-in-class antibody-drug conjugate (ADC) therapies."
  • Earlier, Dr. Cherrington served as CEO of QUE Oncology, and as President and CEO of Arch Oncology, Revitope Oncology, Inc., Zenith Epigenetics, and Pathway Therapeutics.
  • Dr. Sandler is an accomplished leader in oncology and drug development, with experience leading clinical development and operations, regulatory affairs, drug safety and asset development strategy across industry and academia.

Joshua J. Jacobs, MD, FAAOS, Receives American Academy of Orthopaedic Surgeons' Highest Leadership Honor

Retrieved on: 
Wednesday, February 14, 2024
Bangladesh Technical Education Board, SAN, Rush University Medical Center, Research, National Institutes of Health, RUSH, NIH, Rush University, Female, Orthopaedic Research Society, Orthopedic surgery, Life, Learning, Faculty, Mentorship, Rush Medical College, Patient, Health equity, Biology, AAOS, American Academy, Management

The Tipton Leadership Award recognizes AAOS members who have demonstrated outstanding leadership qualities that have benefitted the orthopaedic community, patients and/or the American public.

Key Points: 
  • The Tipton Leadership Award recognizes AAOS members who have demonstrated outstanding leadership qualities that have benefitted the orthopaedic community, patients and/or the American public.
  • "It is a distinctive honor to receive this award.
  • I had the great fortune of working with Dr. Tipton early in my career, when I was 'learning the ropes' of AAOS volunteer service," Dr. Jacobs said.
  • "He was an inspirational leader, who had the ability to evoke the best qualities in people, motivating service for a higher cause."

The Inner Circle Acknowledges, Ryon Hennessy, MD, FAAOS as a Distinguished Pinnacle Professional for his contributions to the Field of Orthopedic Surgery

Retrieved on: 
Thursday, December 21, 2023
Hip, Injury, Rehabilitation, Inner circle, Shoulder, Tendon, Rush University, Multimedia, Knee, Fracture, Joint, Hand, Elbow, MD, Education, American Academy, Northwestern University, Elmhurst Hospital Center, Orthopedic surgery, Field, Ligament, Spine, Patient, Organization, Rush Medical College, Elective surgery, Physician, Ankle, Foot, Dentistry

ELMHURST, Ill., Dec. 21, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Ryon Hennessy, MD, FAAOS is acknowledged as a Distinguished Pinnacle Professional for his contributions to the Field of Orthopedic Surgery.

Key Points: 
  • ELMHURST, Ill., Dec. 21, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Ryon Hennessy, MD, FAAOS is acknowledged as a Distinguished Pinnacle Professional for his contributions to the Field of Orthopedic Surgery.
  • Dr. Hennessy pursued higher education at Northwestern University where he earned a Bachelor of Science degree in Ecology and Evolutionary Biology.
  • He completed a Medical Doctor degree; orthopedic surgery residency; and spinal surgery fellowship at Rush University (Rush Medical College) in Chicago.
  • A board-certified orthopedic surgeon, Dr. Hennessy specializes in knee replacements and fractures and serves patients with issues with bones; ligaments; muscles; joints; nerves; and tendons.

Data Presentation at Association for Molecular Pathology 2023 Validates Performance of SeptiCyte® RAPID in Immunocompromised Patients and Patients on Immunosuppressive Therapy

Retrieved on: 
Friday, November 17, 2023
CEMM, Annual general meeting, Rush Medical College, Risk, Molecular medicine, Experiment, RPD, Patient, Poster, Probability, Infection, Gene expression, MD, Diagnosis, Rush University Medical Center, AMP, Pharmaceutical industry, Sepsis, Immunodeficiency

SEATTLE and BRISBANE, Australia, Nov. 17, 2023 /PRNewswire/ -- Immunexpress, Pty Ltd., a molecular diagnostics company focused on rapid diagnosis and improved outcomes for suspected sepsis patients, today announced a poster presentation validating the utility of SeptiCyte® RAPID in patients who are immunocompromised or are receiving immunosuppressive therapy at the Association for Molecular Pathology (AMP) 2023 Annual Meeting. The poster, entitled "Performance of SeptiCyte® RAPID for Determining Probability of Sepsis in Immunocompromised Patients or Those on Immunosuppressant Therapy," is designated as Poster # ID042 and will be presented on November 17, from 9:15- 10:15 a.m. MT, in Salt Lake City, Utah.

Key Points: 
  • SEATTLE and BRISBANE, Australia, Nov. 17, 2023 /PRNewswire/ -- Immunexpress , Pty Ltd., a molecular diagnostics company focused on rapid diagnosis and improved outcomes for suspected sepsis patients, today announced a poster presentation validating the utility of SeptiCyte® RAPID in patients who are immunocompromised or are receiving immunosuppressive therapy at the Association for Molecular Pathology (AMP) 2023 Annual Meeting.
  • The study compared SeptiCyte RAPID scores with a Retrospective Physician Diagnosis (RPD) across 419 patients to evaluate the efficacy of SeptiCyte RAPID in determining sepsis diagnosis among patients who were immunocompromised or taking immunosuppressive therapy.
  • "SeptiCyte RAPID was effective in determining the likelihood of sepsis diagnosis among a retrospective cohort of patients regardless of immunocompromised status or immunosuppressive therapy administration.
  • "Patients who are immunocompromised or undergoing immunosuppressive therapy are at an increased risk of developing infections and often have abnormal white blood cell counts.

EpiBone Announces Chicago Bulls Physician as Advisor

Retrieved on: 
Tuesday, August 8, 2023
Chicago White Sox, Tissue, Elbow, Shoulder, Joffrey Ballet, Elective surgery, Arthritis, Chicago Bulls, Cartilage, MBA, Cell, Regenerative medicine, Transplant, Publication, MD, Patient, EpiBone, Rush Medical College, Radio, Joint, Entrepreneurship, Rush University Medical Center, Ballet company, B cell, Sports medicine, 1993–94 Chicago Bulls season, Cadaver, Knee, Dentistry, Nursing

JERSEY CITY, N.J., Aug. 8, 2023 /PRNewswire/ -- EpiBone announced today that Brian J. Cole, MD, MBA, a prestigious orthopedic surgeon, professor and researcher at Rush University Medical Center, will serve as an advisor for EpiBone's work in developing living bone and cartilage for human transplantation.

Key Points: 
  • Dr. Brian J. Cole is a sports medicine expert - treating the Chicago Bulls, Chicago White Sox and Joffrey Ballet.
  • Dr. Cole is a managing partner at Midwest Orthopaedics at Rush in Chicago, specializing in shoulder , elbow and knee surgery.
  • An expert in sports medicine, he serves as team physician for the Chicago Bulls basketball team, co-team physician for the Chicago White Sox baseball team and physician for the Joffrey Ballet.
  • "As a well-regarded figure in the world of orthopedics, Dr. Cole will bring invaluable expertise to our work," says Nina Tandon, Co-Founder and CEO of EpiBone.

The Inner Circle Acknowledges, Ryon Hennessy, MD, FAAOS as a Top Pinnacle Professional for his contributions to the Field of Orthopedic Surgery

Retrieved on: 
Tuesday, July 25, 2023
Ankle, Elbow, Hip, Shoulder, Physician, Education, Ligament, Foot, Spine, American Academy, Rehabilitation, Multimedia, Elective surgery, Inner circle, Organization, Field, Rush University, Medicare Physician Group Practice Demonstration, MD, Patient, Fracture, Rush Medical College, Joint, Injury, Orthopedic surgery, Hand, Northwestern University, Tendon, Knee, Elmhurst Hospital Center, Dentistry, Nursing, Ecology

ELMHURST, Ill., July 25, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Ryon Hennessy, MD, FAAOS is acknowledged as a Top Pinnacle Professional for his contributions to the Field of Orthopedic Surgery.

Key Points: 
  • ELMHURST, Ill., July 25, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Ryon Hennessy, MD, FAAOS is acknowledged as a Top Pinnacle Professional for his contributions to the Field of Orthopedic Surgery.
  • Dr. Hennessy pursued higher education at Northwestern University where he earned a Bachelor of Science degree in Ecology and Evolutionary Biology.
  • He completed a Medical Doctor degree; orthopedic surgery residency; and spinal surgery fellowship at Rush University (Rush Medical College) in Chicago.
  • A board-certified orthopedic surgeon, Dr. Hennessy specializes in knee replacements and fractures and serves patients with issues with bones; ligaments; muscles; joints; nerves; and tendons.

The International Myeloma Foundation (IMF) Launches Medical Student Scholars for Health Equity in Myeloma Mentoring Program

Retrieved on: 
Thursday, April 20, 2023
Texas Tech University Health Sciences Center, Health equity, MBA, Harvard Medical School, Patient, Student National Medical Association, Health, MMSc, IMF, Disease, Health and Social Care Select Committee, National Medical Association, Selection Committee, Osteopathy, Multiple myeloma, Philadelphia College of Osteopathic Medicine, FACP, Bone marrow, Research, GA, Organization, Black Ivy League, Karmanos Cancer Institute, SNMA, Diagnosis, McLaren, African Americans, Kansas City metropolitan area, Winship Cancer Institute, International Myeloma Foundation, AL, Memorial Sloan Kettering Cancer Center, Mortality, MPH, Workforce, Mayo, MI, HBCU, Rush Medical College, NMA, Morehouse School of Medicine, Student, Physician, School, Annual general meeting, Nursing, Tutoring, Clothing, Mobile telephony, Ridesharing, MD, University

STUDIO CITY, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) has partnered with the W. Montague Cobb/NMA Health Institute’s Cobb Scholars Program to develop a mentoring program for African American medical school students.

Key Points: 
  • STUDIO CITY, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) has partnered with the W. Montague Cobb/NMA Health Institute’s Cobb Scholars Program to develop a mentoring program for African American medical school students.
  • On how the Medical Student Scholars for Health Equity in Myeloma Mentoring Program came about, Dr. Mikhael narrates: “The Medical Student Scholars for Health Equity in Myeloma is a brand-new program launched by the IMF in collaboration with the National Medical Association and the W. Montague Cobb Institute (their research arm).
  • That's why we are partnering with the W. Montague Cobb/NMA Health Institute’s Cobb Scholars Program and the National Medical Association in creating the Medical Student Scholars for Health Equity in Myeloma Mentoring Program.
  • To learn more about the Medical Student Scholars for Health Equity in Myeloma Mentoring Program, visit the IMF M-Power website .

Immunexpress to Present Data at ECCMID 2023 Indicating that SeptiCyte® RAPID Differentiates Sepsis from Non-Sepsis in Patients with Uncertain Initial Diagnosis

Retrieved on: 
Wednesday, April 5, 2023
SIRS, ESCMID, CET, Classification, Pediatric intensive care unit, Notifiable disease, Sepsis, Congress, Real-time, Hospital, ECCMID, Patient, European, Physician, Systemic inflammatory response syndrome, Rush Medical College, RPD, Diagnosis, Poster, ICU, Intensive care unit, European Society of Clinical Microbiology and Infectious Diseases, Rush University Medical Center, Infection, Medical device, Pharmaceutical industry

The poster presentation, entitled "CLARIFYING UNCERTAINTY IN SEPSIS DIAGNOSIS USING A GENE EXPRESSION ASSAY," #P1673, will be presented in-person at ECCMID on April 16th, 2023, in Copenhagen, Denmark.

Key Points: 
  • The poster presentation, entitled "CLARIFYING UNCERTAINTY IN SEPSIS DIAGNOSIS USING A GENE EXPRESSION ASSAY," #P1673, will be presented in-person at ECCMID on April 16th, 2023, in Copenhagen, Denmark.
  • Additionally, Immunexpress will host a presentation entitled "SeptiCyte RAPID, a unique qPCR host response assay for the rapid and early detection of sepsis," at the ECCMID Innovation Theatre on April 17th, 2023, at 12:30 p.m. CET.
  • The 143 indeterminate patients included in the study were reviewed again, requiring a final adjudication of SIRS or sepsis performed by forced diagnosis with SeptiCyte RAPID.
  • By differentiating sepsis from SIRS, care teams are able to more confidently prescribe antibiotics for sepsis patients as an essential part of their care plan."

The Inner Circle Acknowledges Dahlia M. Rice, MD as a Most Trusted Healthcare Professional for her contributions as a plastic surgeon

Retrieved on: 
Monday, March 27, 2023
Aurora, Plastic surgery, Travel, Food, Education, American Board of Plastic Surgery, Anatomy, Teaching, ABPS, Multimedia, Inner circle, Science, Certification, American Board of Commissioners for Foreign Missions, MD, Patient, Medical Center, Strong Memorial Hospital, Rush Medical College, Aurora St. Luke's Medical Center, Michigan State University, Knowledge, General surgery, Hospital, Dentistry

PLEASANT PRAIRIE, Wis., March 27, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Dahlia M. Rice, MD, is acknowledged as a Most Trusted Healthcare Professional for her contributions as a plastic surgeon.

Key Points: 
  • PLEASANT PRAIRIE, Wis., March 27, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Dahlia M. Rice, MD, is acknowledged as a Most Trusted Healthcare Professional for her contributions as a plastic surgeon.
  • The doctor is a cosmetic plastic and reconstructive surgeon with Aurora Plastic Surgery, based in Pleasant Prairie, WI.
  • She also holds privileges at Aurora Lakeland Medical Center; Aurora Medical Center – Burlington; Aurora Medical Center – Kenosha; and Mt Pleasant, Aurora St Luke's Medical Center; Aurora Medical Center – Grafton; Aurora Sinai Medical Center, Aurora; West Allis Medical Center; and Aurora Medical Center - Summit.
  • The doctor is board certified in plastic surgery through the American Board of Plastic Surgery (ABPS).

Immunexpress to Present Data at ISICEM 2023 Indicating that SeptiCyte® RAPID Outperforms Other Rapid Measures for Sepsis Diagnosis

Retrieved on: 
Tuesday, March 21, 2023
Emergency medicine, SOFA, Respiratory rate, Temperature, Inflammation, Septic shock, PCT, Messenger, Sonneborn–Berger score, Intensive care medicine, International Symposium on Endovascular Therapy, Systemic inflammatory response syndrome, AUC, Rush Medical College, Diagnosis, Mortality, ICU, Intensive care unit, Rush University Medical Center, Gene, Critical Care Medicine (journal), SIRS, Medical imaging, Pharmaceutical industry, Sepsis, Patient

The poster presentation, entitled "Performance of a Molecular Host Response Assay in Patients Suspected of Sepsis and Stratified by qSOFA," will be presented on March 21, 2023.

Key Points: 
  • The poster presentation, entitled "Performance of a Molecular Host Response Assay in Patients Suspected of Sepsis and Stratified by qSOFA," will be presented on March 21, 2023.
  • The abstract will be published in Critical Care Medicine and will be available at www.septicyte.com/references .
  • SeptiCyte® RAPID differentiates sepsis positive patients from sepsis negative patients irrespective of qSOFA stratification (AUC 0.82 in qSOFA ≥2, AUC 0.81 in qSOFA
  • SeptiCyte RAPID outperformed other markers of sepsis at separating both higher and lower mortality ICU cases from patients that did not have sepsis.